Home ‹ Helminths (including anthelmintic resistance) ‹ [Risk assessment methodologies] – Risk assessment methodologies – Helminths
Helminths (including anthelmintic resistance) roadmap:
Therapeutics

Roadmap for development of therapeutics for helminths

Download Helminths-Therapeutic-Tests-Roadmap

3

Risk assessment methodologies

visit roadmap

Dependencies

  • 4 Minimum Viable Product Profile
  • 7 Alternatives to animal testing
  • 7A Replace
  • 7B Reduce
  • 7C Refine

Next steps

Risk assessment methodologies

Research Question

What are we trying to achieve and why? What is the problem we are trying to solve?

 

Research Gaps and Challenges

What are the scientific and technological challenges (knowledge gaps needing to be addressed)?

 

Solution Routes

What approaches could/should be taken to address the research question?

 

Dependencies

What else needs to be done before we can solve this need?

 

State Of the Art

Existing knowledge including successes and failures

 

Projects

What activities are planned or underway?

Single-nucleotide polymorphisms in the beta-tubulin gene and its relationship with treatment response to albendazole in human soil-transmitted helminths in Southern Mozambique

Planned Completion date 14/09/2022

Source Countries:

NetherlandsIconNetherlands

An integrated set of novel approaches to counter the emergence and proliferation of invasive and virulent soil-borne nematodes – Project part: Fostering nematode suppression in soils by cover crops and addition of biological antagonists in Organic Farming (NEM-EMERGE)

Planned Completion date 31/12/2027

Source Countries:

DenmarkIconDenmark